Research Article

Strategy for the Management of Macular Edema in Retinal Vein Occlusion: The European VitreoRetinal Society Macular Edema Study

Table 3

Baseline demographic patient data for all RVO.

Number of casesMean pretreatment Va LogMAR (Snellen)Standard deviationMean number of treatments

MonotherapyAnti-VEGF alone2510.85 (0.14)0.474.45
PPV with ILM peeling alone 1281 (0.10)0.491.00
Dexamethasone implant alone370.68 (0.25)0.41.64
Triamcinolone alone 271.04 (0.09)0.481.00

Combination therapyAnti-VEGF (1) + grid (2)720.80 (0.16)0.45(1) 4.58 
(2) 0.88
Anti-VEGF (1) + triamcinolone (2)370.96 (0.11)0.49(1) 3.16 
(2) 1.04
Anti-VEGF (1) + grid (2) + triamcinolone (3)270.78 (0.17)0.41(1) 2.79 
(2) 1.52 
(3) 1.07
Triamcinolone (1) + PPV with ILM peeling (2)230.90 (0.13)0.47(1) 1.15 
(2) 1.00

RVO: retinal vein occlusion.
VEGF: vascular endothelial growth factor.
PPV: pars plana vitrectomy.
ILM: internal limiting membrane.